Haibo Sun

Jiangsu Key Laboratory Of Experimental And
Yangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Next-generation CAR-T cell engineering by Chinese scientists: Structural innovation, tumor microenvironment remodeling, and clinical translation.

Next-generation CAR-T cell engineering by Chinese scientists: Structural innovation, tumor microenvironment remodeling, and clinical translation.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: February 08, 2026

Alternative Splicing in Cyclin-Dependent Kinase 4/6 Inhibitor Resistance in Estrogen Receptor-Positive Breast Cancer.

Alternative Splicing in Cyclin-Dependent Kinase 4/6 Inhibitor Resistance in Estrogen Receptor-Positive Breast Cancer.

Journal: Drug development research

Published: January 20, 2026

PROTAC: a revolutionary technology propelling small molecule drugs into the next golden age.

PROTAC: a revolutionary technology propelling small molecule drugs into the next golden age.

Journal: Frontiers in oncology

Published: July 30, 2025

SYT15B promotes tumor progression through interaction with IQGAP1 to activate the MAPK pathway in lung adenocarcinoma.

SYT15B promotes tumor progression through interaction with IQGAP1 to activate the MAPK pathway in lung adenocarcinoma.

Journal: Cellular signalling

Published: July 25, 2025

Prognostic value of metal-based ferroptosis and cuproptosis genes and score in lower grade gliomas.

Prognostic value of metal-based ferroptosis and cuproptosis genes and score in lower grade gliomas.

Journal: Frontiers in immunology

Published: April 08, 2025

Integrative analysis of T cell-associated markers in Ewing sarcoma reveals prognostic signatures and immune dynamics.

Integrative analysis of T cell-associated markers in Ewing sarcoma reveals prognostic signatures and immune dynamics.

Journal: Frontiers in immunology

Published: March 03, 2025

Editorial: Specific targeting of MHC antigens for T-cells and immune cells in human disease.

Editorial: Specific targeting of MHC antigens for T-cells and immune cells in human disease.

Journal: Frontiers in immunology

Published: December 05, 2024

Downregulation of the splicing regulator NSRP1 confers resistance to CDK4/6 inhibitors via activation of interferon signaling in breast cancer.

Downregulation of the splicing regulator NSRP1 confers resistance to CDK4/6 inhibitors via activation of interferon signaling in breast cancer.

Journal: The Journal of biological chemistry

Published: July 16, 2024

SNRPB2 promotes triple-negative breast cancer progression by controlling alternative splicing of MDM4 pre-mRNA.

SNRPB2 promotes triple-negative breast cancer progression by controlling alternative splicing of MDM4 pre-mRNA.

Journal: Cancer science

Published: June 27, 2024

Unraveling the complex landscape of endocrine resistance in breast cancer: Emerging role of long noncoding RNA AGPG and beyond.

Unraveling the complex landscape of endocrine resistance in breast cancer: Emerging role of long noncoding RNA AGPG and beyond.

Journal: Chinese medical journal

Published: April 28, 2024

Utilizing a structure-based virtual screening approach to discover potential LSD1 inhibitors.

Utilizing a structure-based virtual screening approach to discover potential LSD1 inhibitors.

Journal: Journal of cancer research and clinical oncology

Published: April 15, 2024

Engineering and targeting potential of CAR NK cells in colorectal cancer.

Engineering and targeting potential of CAR NK cells in colorectal cancer.

Journal: Chinese medical journal

Published: April 04, 2024

Showing 1-12 of 30

Last Updated: 09/26/2026